EP0316712A2 — 22-Dechloroteicoplanins
Assigned to Gruppo Lepetit SpA · Expires 1989-05-24 · 37y expired
What this patent protects
The present invention is directed to new 22-dechloro derivatives of the antibiotic teicoplanin having the following formula: <CHEM> wherein: Y represents hydroxy, an ester function or an amide function, A represents hydrogen or -N[(C10-C11)aliphatic acyl]-beta-D-2-deoxy-2…
USPTO Abstract
The present invention is directed to new 22-dechloro derivatives of the antibiotic teicoplanin having the following formula: <CHEM> wherein: Y represents hydroxy, an ester function or an amide function, A represents hydrogen or -N[(C10-C11)aliphatic acyl]-beta-D-2-deoxy-2-amino-glucopyranosyl, B represents hydrogen or N-acetyl-beta-D-2-deoxy-amino-glucopyranosyl M represents hydrogen or alpha-D-mannopyranosyl; and the addition salts thereof, to a method for their preparation and to the pharmaceutical compositions containing them.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.